These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6163385)

  • 21. Bleomycin-induced Raynaud's phenomenon.
    Kukla LJ; Burrows D; Bressler L; McGuire WP
    Arch Dermatol; 1981 Oct; 117(10):604. PubMed ID: 6169311
    [No Abstract]   [Full Text] [Related]  

  • 22. Raynaud's phenomenon after bleomycin treatment.
    Chernicoff DP; Bukowski RM; Young JR
    Cancer Treat Rep; 1978 Apr; 62(4):570-1. PubMed ID: 77728
    [No Abstract]   [Full Text] [Related]  

  • 23. [Raynaud's phenomenon induced by bleomycin: a clinical case].
    Niklander C; Guzmán L
    Rev Med Chil; 1988 Dec; 116(12):1302-5. PubMed ID: 2477885
    [No Abstract]   [Full Text] [Related]  

  • 24. Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold.
    Hansen SW; Olsen N
    J Clin Oncol; 1989 Jul; 7(7):940-2. PubMed ID: 2472472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
    von Gunten CF; Roth EL; Von Roenn JH
    Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raynaud's phenomenon after bleomycin treatment.
    Sundstrup B
    Med J Aust; 1978 Sep; 2(6):266. PubMed ID: 83530
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic bleomycin-associated Raynaud's phenomenon.
    Soble AR
    Cancer Treat Rep; 1978 Apr; 62(4):570. PubMed ID: 77727
    [No Abstract]   [Full Text] [Related]  

  • 28. Intralesional bleomycin and Raynaud's phenomenon.
    Gregg LJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):279-80. PubMed ID: 1372624
    [No Abstract]   [Full Text] [Related]  

  • 29. Intralesional bleomycin and Raynaud's phenomenon.
    Epstein E
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):785-6. PubMed ID: 1714468
    [No Abstract]   [Full Text] [Related]  

  • 30. Raynaud's phenomenon and intralesional bleomycin.
    de Pablo P; Aguillar A; Gallego MA
    Acta Derm Venereol; 1992 Nov; 72(6):465. PubMed ID: 1283475
    [No Abstract]   [Full Text] [Related]  

  • 31. Persisting Raynaud's phenomenon following intralesional bleomycin treatment of finger warts.
    Epstein E
    J Am Acad Dermatol; 1985 Sep; 13(3):468-71. PubMed ID: 2414348
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.
    Hansen SW; Olsen N; Rossing N; Rørth M
    Ann Oncol; 1990 Jul; 1(4):289-92. PubMed ID: 1702313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raynaud's phenomenon of a single digit following local intradermal bleomycin sulfate injection.
    Smith EA; Harper FE; LeRoy EC
    Arthritis Rheum; 1985 Apr; 28(4):459-61. PubMed ID: 2580538
    [No Abstract]   [Full Text] [Related]  

  • 34. [Raynaud's phenomenon following treatment with cytostatics].
    Haastrup U; Storm TL
    Ugeskr Laeger; 1985 Dec; 147(49):4010. PubMed ID: 2418566
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.
    Stefenelli T; Kuzmits R; Ulrich W; Glogar D
    Eur Heart J; 1988 May; 9(5):552-6. PubMed ID: 2456930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon following cytotoxic chemotherapy successfully managed by dorsal sympathectomy.
    MacLeod PM; Tyrrell CJ; Bliss B
    Eur J Surg Oncol; 1989 Feb; 15(1):79-81. PubMed ID: 2465189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Raynaud syndrome and changes in lung function as sequelae of cytostatic therapy of testicular tumors].
    Creutzig A; Pölking W; Schmoll HJ; Fabel H; Alexander K
    Med Klin (Munich); 1987 Feb; 82(4):131-4. PubMed ID: 2436030
    [No Abstract]   [Full Text] [Related]  

  • 38. Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
    McGrath SE; Webb A; Walker-Bone K
    J Clin Oncol; 2013 Feb; 31(4):e51-2. PubMed ID: 23270004
    [No Abstract]   [Full Text] [Related]  

  • 39. First report of a vincristine dose-related Raynaud's phenomenon in an adolescent with malignant brain tumor.
    Gottschling S; Meyer S; Reinhard H; Krenn T; Graf N
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):768-9. PubMed ID: 15543016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.
    Heier MS; Nilsen T; Graver V; Aass N; Fosså SD
    Br J Cancer; 1991 Apr; 63(4):550-2. PubMed ID: 1850610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.